A study by researchers at the University of California, San Diego (UCSD) has brought unravelling the evolution of HIV-1 closer, by revealing that an essential component of the HIV-1 molecular machinery, which is responsible for infecting cells, consists of functionally-specialized layers.
Published in PLoS Computational Biology, a report on the study suggests that the unprecedented genetic diversity and adaptability of HIV-1 has so far foiled the best efforts to eradicate the global HIV/AIDS epidemic.
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with precautions. AIDS/HIV symptoms manifest long after the actual infection occurs.
Advertisement
The surface of the HIV-1 particle is studded with protein spikes that allow the virus to enter human cells.
During the study, the researchers examined an important component of the protein spike called the third variable loop (V3).
According to them, protein components like V3 are problematic because they are very diverse. They say that up to 35 per cent of the amino acids can differ between strains of HIV-1.
![HIV Vaccine Gets a Booster from Immune System]( "HIV Vaccine Gets a Booster from Immune System")
Experiments have shown that the immune system could be stimulated to wade off AIDS by improving the effectiveness of DNA vaccines.
Upon being exposed to human antibodies, say the researchers, V3 rapidly evolves to avoid the immune system.
They, however, say that the V3 loop's critical function as a docking mechanism for HIV-1 to infect cells should impose limits on these evolutionary contortions.
It is believed that deciphering the hidden limits on HIV-1 evolution may facilitate the development of antiviral drugs and vaccines.
The researchers developed a new method by combining techniques from molecular evolution and artificial intelligence. They reconstructed the evolutionary history underlying 1,145 genetic sequences encoding the V3 loop to discover groups of amino acids that were biologically dependent on each other.
The "co-evolving" amino acids formed ties across the V3 loop like rungs on a ladder, corroborating models from structural studies of the same protein.
Although the study was restricted to a small portion of the genome, the researchers say that it represents a significant advancement in the understanding of HIV-1 evolution and identifies important targets in the protein spike for future research.
Source: ANI
SRM/P
According to them, protein components like V3 are problematic because they are very diverse. They say that up to 35 per cent of the amino acids can differ between strains of HIV-1.
HIV Vaccine Gets a Booster from Immune System
Experiments have shown that the immune system could be stimulated to wade off AIDS by improving the effectiveness of DNA vaccines.
Advertisement
Upon being exposed to human antibodies, say the researchers, V3 rapidly evolves to avoid the immune system.
They, however, say that the V3 loop's critical function as a docking mechanism for HIV-1 to infect cells should impose limits on these evolutionary contortions.
It is believed that deciphering the hidden limits on HIV-1 evolution may facilitate the development of antiviral drugs and vaccines.
The researchers developed a new method by combining techniques from molecular evolution and artificial intelligence. They reconstructed the evolutionary history underlying 1,145 genetic sequences encoding the V3 loop to discover groups of amino acids that were biologically dependent on each other.
The "co-evolving" amino acids formed ties across the V3 loop like rungs on a ladder, corroborating models from structural studies of the same protein.
Although the study was restricted to a small portion of the genome, the researchers say that it represents a significant advancement in the understanding of HIV-1 evolution and identifies important targets in the protein spike for future research.
Source: ANI
SRM/P
Advertisement
Advertisement
|
Advertisement
Latest AIDS/HIV News
Though monkeypox can affect anyone, CDC research states that approximately 40% of people diagnosed with monkeypox in the US also test positive for HIV.
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.